P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines: Evidence for a saturation of active daunorubicin transport
- 1 February 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (3) , 349-359
- https://doi.org/10.1016/0006-2952(91)90531-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The polyoxyethylene castor oil Cremophor EL modifies multidrug resistanceBritish Journal of Cancer, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometryCancer Chemotherapy and Pharmacology, 1989
- Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cellsThe FASEB Journal, 1988
- Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and-sensitive cell linesCancer Chemotherapy and Pharmacology, 1987
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986
- Calcium Channel Blocker Enhancement of Anticancer Drug Cytotoxicity—A ReviewCancer Drug Delivery, 1984
- Identification of two distinct regulatory regions adjacent to the human β-interferon geneCell, 1983
- A flow-through tissue culture system with fast dynamic responseAnalytical Biochemistry, 1982